CN112898410A - Tachypleus tridentatus hemocyanin and preparation method and application thereof - Google Patents
Tachypleus tridentatus hemocyanin and preparation method and application thereof Download PDFInfo
- Publication number
- CN112898410A CN112898410A CN202110109125.8A CN202110109125A CN112898410A CN 112898410 A CN112898410 A CN 112898410A CN 202110109125 A CN202110109125 A CN 202110109125A CN 112898410 A CN112898410 A CN 112898410A
- Authority
- CN
- China
- Prior art keywords
- hemocyanin
- horseshoe crab
- solution
- preparation
- centrifugation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108060003552 hemocyanin Proteins 0.000 title claims abstract description 70
- 241000239224 Tachypleus tridentatus Species 0.000 title claims abstract description 22
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 239000000243 solution Substances 0.000 claims abstract description 36
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 28
- 241000239218 Limulus Species 0.000 claims abstract description 25
- 241001529572 Chaceon affinis Species 0.000 claims abstract description 23
- 210000002381 plasma Anatomy 0.000 claims abstract description 22
- 238000005119 centrifugation Methods 0.000 claims abstract description 21
- 239000008055 phosphate buffer solution Substances 0.000 claims abstract description 19
- 238000000034 method Methods 0.000 claims abstract description 18
- 239000006228 supernatant Substances 0.000 claims abstract description 13
- 239000002244 precipitate Substances 0.000 claims abstract description 12
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 238000000502 dialysis Methods 0.000 claims abstract description 8
- 235000013305 food Nutrition 0.000 claims abstract description 8
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 6
- 238000002156 mixing Methods 0.000 claims abstract description 6
- 239000000287 crude extract Substances 0.000 claims abstract description 5
- 239000002699 waste material Substances 0.000 claims abstract description 4
- 239000011259 mixed solution Substances 0.000 claims abstract description 3
- 239000003963 antioxidant agent Substances 0.000 claims description 6
- 239000005452 food preservative Substances 0.000 claims description 2
- 235000019249 food preservative Nutrition 0.000 claims description 2
- 239000000463 material Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 6
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 239000012460 protein solution Substances 0.000 claims 1
- 229940079593 drug Drugs 0.000 abstract description 4
- 238000007254 oxidation reaction Methods 0.000 abstract description 4
- 230000003647 oxidation Effects 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 238000002835 absorbance Methods 0.000 description 19
- 239000000523 sample Substances 0.000 description 12
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 9
- 108090000765 processed proteins & peptides Proteins 0.000 description 9
- 239000000843 powder Substances 0.000 description 8
- 241000239221 Tachypleus gigas Species 0.000 description 7
- 238000003860 storage Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 6
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 6
- 150000003254 radicals Chemical class 0.000 description 6
- 241000238421 Arthropoda Species 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 239000000413 hydrolysate Substances 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000002000 scavenging effect Effects 0.000 description 5
- -1 superoxide radicals Chemical class 0.000 description 5
- 102000009027 Albumins Human genes 0.000 description 4
- 108010088751 Albumins Proteins 0.000 description 4
- 241000209094 Oryza Species 0.000 description 4
- 235000007164 Oryza sativa Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000004108 freeze drying Methods 0.000 description 4
- 235000009566 rice Nutrition 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 3
- 239000013067 intermediate product Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 150000002978 peroxides Chemical class 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940079877 pyrogallol Drugs 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- GLDQAMYCGOIJDV-UHFFFAOYSA-N 2,3-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC(O)=C1O GLDQAMYCGOIJDV-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- 102000001554 Hemoglobins Human genes 0.000 description 2
- 108010054147 Hemoglobins Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 238000010266 Sephadex chromatography Methods 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- ABBQHOQBGMUPJH-UHFFFAOYSA-M Sodium salicylate Chemical compound [Na+].OC1=CC=CC=C1C([O-])=O ABBQHOQBGMUPJH-UHFFFAOYSA-M 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 2
- 235000011130 ammonium sulphate Nutrition 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 239000000385 dialysis solution Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 210000000087 hemolymph Anatomy 0.000 description 2
- 230000007062 hydrolysis Effects 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- TUJKJAMUKRIRHC-UHFFFAOYSA-N hydroxyl Chemical compound [OH] TUJKJAMUKRIRHC-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229960004025 sodium salicylate Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000000967 suction filtration Methods 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 229940082044 2,3-dihydroxybenzoic acid Drugs 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 101800000068 Antioxidant peptide Proteins 0.000 description 1
- 108091005658 Basic proteases Proteins 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 102100035882 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 102000003820 Lipoxygenases Human genes 0.000 description 1
- 108090000128 Lipoxygenases Proteins 0.000 description 1
- 241000361919 Metaphire sieboldi Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 230000031700 light absorption Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000006864 oxidative decomposition reaction Methods 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000005502 peroxidation Methods 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 238000004007 reversed phase HPLC Methods 0.000 description 1
- 229960001860 salicylate Drugs 0.000 description 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3526—Organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Microbiology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Compounds Of Unknown Constitution (AREA)
- Cosmetics (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention relates to the field of biotechnology, in particular to Tachypleus tridentatus hemocyanin with antioxidant activity and a preparation method thereof. The preparation method comprises the following steps: (1) removing the precipitate after the low-temperature low-speed primary centrifugation of the blood plasma of the tachypleus tridentatus and reserving the supernatant; (2) mixing the supernatant with a saturated ammonium sulfate solution and standing for 10-24 hours; (3) collecting the precipitate after the low-temperature low-speed secondary centrifugation of the mixed solution, and suspending the precipitate in PBS (phosphate buffer solution) with the pH value of 7.0-7.6 to obtain a horseshoe crab hemocyanin crude extract; (4) filling the crude extract into a dialysis bag, and dialyzing at 0-4 ℃ for 12-48 h. The limulus tridentatus hemocyanin with the antioxidant activity is obtained by the method. The method uses the Tachypleus tridentatus waste plasma remained in the preparation of the limulus reagent as a raw material, reduces the cost, is simple to operate, saves the time, obtains the Tachypleus tridentatus hemocyanin with stronger oxidation resistance, can be used for storing medicines, cosmetics, foods and the like, and has good market prospect and industrial value.
Description
Technical Field
The invention relates to the field of biotechnology, in particular to a Tachypleus tridentatus hemocyanin with antioxidant activity and a preparation method and application of freeze-dried powder of the Tachypleus tridentatus hemocyanin.
Background
Hemocyanin is a protein widely present in arthropod and mollusk hemolymph, and is called three respiratory proteins in nature together with hemoglobin and earthworm hemoglobin. However, as the research progresses, it has been found that the function of hemocyanin is far from this, and hemocyanin is involved in storage of energy, molting of animals, regulation of immune function, and the like in addition to oxygen transport in arthropods. Chinese horseshoe crab is an arthropod living in seabed. The blood of Tachypleus tridentatus, a member of arthropods, contains a large amount of hemocyanin. The research proves that the hemocyanin has various catalytic effects, and the hemocyanin can denaturalize and express the activities of phenol oxidase, catalase, lipoxygenase and the like under specific conditions.
Cosmetics are highly popular commodities, and their consumption is moving with the social trend, and have a distinct epoch characteristic. With the improvement of the quality of life accompanied by economic development, how to delay the aging process becomes the most popular topic. Nowadays, the age-old population characteristics and the special industrial background of cosmetics provide wide space for the application of natural extracts with physiological activities such as free radical resistance, oxidation resistance and the like. With the intensive research on the theory of free radicals, natural extracts having antioxidant activity are also increasingly used in the pharmaceutical industry and food storage.
CN104788541A discloses a preparation method of small peptide with antioxidant activity, wheat germ albumin is subjected to enzymolysis by trypsin to obtain albumin hydrolysate I; taking the components with the molecular weight less than 10KDa in the hydrolysate I, and separating by adopting gel filtration chromatography to obtain the components with antioxidant activity as albumin extract II; carrying out enzymolysis on the extract II by using alkaline protease to obtain an albumin hydrolysate III; and separating the hydrolysate III by gel filtration chromatography and reversed-phase high performance liquid chromatography in sequence to obtain the small peptide with antioxidant activity.
CN102080118A discloses a preparation method of rice bran antioxidant active protein peptide, wherein fresh rice bran is subjected to low-temperature degreasing treatment, rice bran protein is prepared by an alkaline method, and rice bran antioxidant peptide is prepared by using compound protease.
The existing methods are complex in preparation method, and finished products are not easy to store and transport.
Tachypleus tridentatus, a kind of arthropod, has a large amount of hemocyanin in hemolymph. Because of the need to produce limulus reagents, Tachypleus tridentatus is often taken to collect blood, blood cells are used to produce limulus reagents, and the remaining plasma is discarded completely. In fact, these discarded plasmas still contain large amounts of hemocyanin. These hemocyanins existing in the plasma of horseshoe crab can be utilized.
The inventor finds that the residual blood plasma is used for preparing the hydrolysis peptide with the antioxidant activity, and CN106148465A discloses the limulus plasma protein hydrolysis peptide with the antioxidant activity and a preparation method and application thereof, wherein the limulus plasma is subjected to constant-temperature water bath heat treatment denaturation at the temperature of 70-100 ℃, and then the limulus plasma is subjected to suction filtration and is washed by water; hydrolyzing the obtained limulus plasma by using protease, and then centrifuging the limulus plasma hydrolysate to obtain supernatant; passing the obtained supernatant through Sephadex G-50 Sephadex column, and collecting the component with maximum absorbance at wavelength of 230nm to obtain limulus plasma proteolytic peptide.
The raw material of the method is horseshoe crab plasma, the hydrolysis peptide with antioxidant activity is obtained, the steps of suction filtration, enzymolysis and the like are needed, and the sephadex chromatography method is adopted, so that the sephadex chromatography operation is complex, the experiment consumes long time, and the column loading, the column bed pH adjustment and the repeated balance of the chromatographic column by buffer solution are needed before the experiment, which takes time; chromatography columns are also prone to clogging during the experiment, take more time to process once clogged, and are of narrow use, mainly food and drugs. And has the problems of inconvenient product storage and transportation and the like.
Therefore, the prior art has the disadvantages of complicated operation, long time consumption, narrow application of the prepared hydrolyzed peptide, and difficult preservation of the prepared hydrolyzed peptide.
Based on the hemocyanin and the freeze-dried powder with the antioxidant activity, the hemocyanin and the freeze-dried powder with the antioxidant activity are developed, and the aim is to efficiently and simply obtain the hemocyanin with the antioxidant activity so as to meet the market demand.
Disclosure of Invention
The invention aims to provide limulus tridentatus hemocyanin with antioxidant activity, freeze-dried powder and a preparation method thereof.
A method for preparing horseshoe crab hemocyanin comprises the following steps:
(1) removing the precipitate after the low-temperature low-speed primary centrifugation of the blood plasma of the tachypleus tridentatus and taking the supernatant;
(2) and (2) mixing the supernatant obtained by the primary centrifugation in the step (1) with a saturated ammonium sulfate solution according to the ratio of 1: mixing the materials in a volume ratio of 1.5-3, and standing for 10-24 h;
(3) performing low-temperature low-speed secondary centrifugation on the mixed solution after placement in the step (2), collecting precipitates, and suspending the precipitates in a PBS (phosphate buffer solution) with the pH value of 7.0-7.6 to obtain a horseshoe crab hemocyanin crude extract;
(4) and (3) adding the crude limulus hemocyanin extracting solution obtained in the step (3) into a dialysis bag, dialyzing for 12-48 h at 0-4 ℃ by using PBS (phosphate buffer solution) with the pH of 7.0-7.6, and taking a part with the molecular weight of more than or equal to 3500 Da.
The primary centrifugation in the step (1) and the secondary centrifugation in the step (3) are carried out, wherein the centrifugation temperature is 0-4 ℃, the centrifugation speed is 6000-8000 rpm, and the time is 0.5-2 h. More preferably, the temperature of the primary centrifugation or the secondary centrifugation is 4 ℃, the centrifugation speed is 8000rpm, and the time is 1 h.
Preferably, the pH of the saturated ammonium sulfate solution in step (2) is 7.
Preferably, in the step (2), the volume ratio of the supernatant to the saturated ammonium sulfate solution is 1: 2.
the preparation method of the saturated ammonium sulfate solution in the step (2) comprises the following steps: dissolving ammonium sulfate in water at 55-65 ℃, cooling to room temperature, filtering, and adjusting the pH of the filtrate to 7.0 by using ammonia water.
In the step (2), a saturated ammonium sulfate solution is slowly added dropwise to the supernatant.
In steps (3) and (4), the pH of the PBS solution is preferably 7.0.
In steps (3) and (4), the concentration of the PBS solution is 0.005 to 0.1mol/L, more preferably 0.005 to 0.05 mol/L. In a preferred embodiment of the present invention, the PBS solution has a pH of 7.0 and a concentration of 0.01 mol/L.
In the step (4), the dialysis time is 24h, and the dialysis solution is replaced at the 2h, 8h and 22h of dialysis respectively.
Preferably, the limulus tridentatus plasma of step (1) is limulus tridentatus waste plasma remaining after the limulus reagent preparation.
And (4) carrying out freeze drying, vacuum freeze drying or spray drying on the hemocyanin solution obtained in the step (4) to obtain the limulus hemocyanin freeze-dried powder.
Preferably, the hemocyanin solution of Tachypleus tridentatus obtained in the step (4) is freeze-dried by a vacuum freeze-dryer and ground into powder by a low-temperature grinder. More preferably, the temperature of freeze drying is-70 to-80 ℃, and the time is 48 to 96 hours. More preferably, the temperature of the freeze-drying is-80 ℃ and the time is 72 hours.
A Tachypleus tridentatus hemocyanin is prepared by the above method.
The Tachypleus tridentatus hemocyanin has good antioxidant activity, and can be used for preparing antioxidant. The Chinese horseshoe crab hemocyanin can be used for preparing cosmetics, foods, food preservatives or medicines, and is applied to the fields of functional foods, food storage and preservation, pharmacy and cosmetics.
A pharmaceutical or cosmetic with antioxidant activity contains the above Tachypleus tridentatus hemocyanin. Preferably, the above horseshoe crab hemocyanin is used as an active ingredient.
The limulus tridentatus hemocyanin obtained by the method has strong oxidation resistance, and can effectively eliminate various free radicals and peroxides and inhibit the generation of the free radicals and the peroxides, such as superoxide, superoxide radicals, hydroxyl free radicals, hydrogen peroxide and peroxides generated by lipid.
The invention has the beneficial effects that:
(1) the limulus hemocyanin with the antioxidant activity is obtained by taking the Chinese limulus waste plasma remained in the limulus reagent preparation as a raw material, so that byproducts are fully utilized, and the cost is reduced;
(2) the extraction and preparation method is simple, and the time is saved; the method of ammonium sulfate fractional precipitation and dialysis is adopted, the whole operation is simple, convenient and quick, and the obtained tachypleus tridentatus hemocyanin has good anti-oxidation effect;
freeze-drying and grinding the purified horseshoe crab hemocyanin into powder, which not only facilitates storage and transportation, but also ensures that the quality problems of protein character change and the like of the horseshoe crab hemocyanin in China cannot occur in the subsequent use process;
(3) the obtained limulus hemocyanin product has strong antioxidant activity and wide application, can be widely used in antioxidant markets as an antioxidant, such as the fields of medicines, food storage and preservation, cosmetic preparation and the like, and has good market prospect and industrial value.
Detailed Description
The technical solution of the present invention will be described below with reference to specific examples.
Example 1
A method for preparing Tachypleus tridentatus hemocyanin with antioxidant activity comprises the following steps:
(1) taking out the residual blood plasma of Tachypleus tridentatus from a refrigerator at minus 80 ℃, and sequentially thawing in a refrigerator at minus 20 ℃ and 4 ℃;
(2) and after the plasma is completely thawed, taking 5mL of the plasma in a centrifuge tube, and centrifuging at a low temperature and a low speed under the conditions of 4 ℃ of temperature, 8000rpm/min of rotation speed and 1h of centrifugation time. And (4) discarding the precipitate after the centrifugation is finished, and keeping the supernatant for later use.
(3) Taking the supernatant and a saturated ammonium sulfate solution with the pH value of 7.0, and using a liquid transfer gun to transfer the saturated ammonium sulfate solution into a liquid state according to the weight ratio of 2: 1, dropwise and slowly adding the mixture into the supernatant obtained in the step (2); the resulting suspension was placed in a refrigerator at 4 ℃ overnight.
(4) Taking the suspension, centrifuging at low temperature and low speed under the conditions of 4 ℃, 8000rpm/min of rotation speed and 1h of centrifugation time. And (3) observing blue precipitates of the Chinese horseshoe crab hemocyanin at the bottom after the centrifugation is finished, discarding supernate, and suspending the precipitates in PBS (phosphate buffer solution) with the pH value of 7.0 to obtain the crude extract of the horseshoe crab hemocyanin.
(5) Adding the crude extractive solution of Limulus hemocyanin into dialysis bag of MD3500, standing at 4 deg.C for 24 hr, and respectively replacing dialysis solution at 2 hr, 8 hr, and 22 hr after dialysis. The dialyzed solution was 0.01mol/L PBS solution at pH 7.0. Taking the part with molecular weight more than or equal to 3500 Da.
(6) Freezing and crystallizing the dialyzed limulus hemocyanin solution at-80 deg.C for 72 hr, grinding into powder with low temperature grinder, and storing at 4 deg.C.
Example 2 determination of the antioxidant Activity of Limulus tridentatus hemocyanin
(1) Determination of superoxide radical scavenging Capacity
Superoxide radical is one of the most abundant oxygen radicals produced in the body. Pyrogallol is subjected to oxidative decomposition under the condition of alkaline (pH8.2) buffer solvent to generate superoxide anion and yellow intermediate product, and the intermediate product has maximum absorption peak at the wavelength of 320 nm. When antioxidant substances are added into the reaction system, the oxidation reaction of the pyrogallol is inhibited, the intermediate product is reduced, and the light absorption value of the sample solution at 320nm is weakened. The specific steps for measuring the scavenging capacity of the superoxide radical are as follows:
taking 0.5mL of Tachypleus tridentatus hemocyanin solution into a sample tube, adding 2.3mL of 50mmol/L Tris-HCl buffer solution with the pH value of 8.2, adding 20 mu L of 10mmol/L pyrogallol, quickly and uniformly mixing for reaction, measuring the absorbance at 320nm after 1min, and recording the absorbance value every 30s until the reaction is carried out for 6 min. According to the formula [ ABlank space-(ASample (I)-AControl)]/ABlank spaceX 100 calculation of clearance, where ABlank spaceI.e. absorbance, A, of the treatment groups without addition of hemocyaninSample (I)I.e. absorbance, A, of the treatment group to which hemocyanin was addedControlI.e. the absorbance of only hemocyanin.
The results show that the Chinese horseshoe crab hemocyanin eliminates the IC of superoxide radical50The value was 0.42 mg/mL.
(2) Determination of Hydrogen peroxide scavenging Capacity
The capacity of hydrogen peroxide scavenging is determined by reference to the method of Gulcin, and the specific steps are as follows: taking 3.4mL of hemocyanin solution to a sample tube, adding 0.6mL of 40mmol/L H2O2And (3) solution. Standing for 200min, zeroing with distilled water, and measuring absorbance at 230 nm. According to the formula [ ABlank space-(ASample (I)-AControl)]/ABlank spaceX 100 calculation of clearance, where ABlank spaceI.e. absorbance, A, of the treatment groups without addition of hemocyaninSample (I)I.e. absorbance, A, of the treatment group to which hemocyanin was addedControlI.e. the absorbance of only hemocyanin.
IC for eliminating hydrogen peroxide from Chinese horseshoe crab hemocyanin50The value was 0.89 mg/mL.
(3) Determination of anti-lipid peroxidation Capacity
Referring to the method of Zain, 200g of lecithin was dissolved in 200mL of 0.1mol/L phosphate buffer solution pH7.4 and dissolved with shaking in ice bath. Taking 4mL of hemocyanin solution, adding 3.6mL of lecithin solution, 0.4mL of 10mmol/L ferrous dichloride solution and 0.4mL of 10mmol/L VC solution into a sample tube. And carrying out constant temperature water bath at 37 ℃ in dark for 60 min. Cooled to room temperature, 1mL of 0.8% TBA solution and 1mL of 20% TCA solution were added, respectively, to the mixture in a boiling water bath for 15min, cooled to room temperature and centrifuged for 10min, and the absorbance at 535nm was measured.
According to the formula [ ABlank space-(ASample (I)-AControl)]/ABlank spaceX 100 calculation of clearance, where ABlank spaceI.e. absorbance, A, of the treatment groups without addition of hemocyaninSample (I)I.e. absorbance, A, of the treatment group to which hemocyanin was addedControlI.e. the absorbance of only hemocyanin.
IC for resisting lipid peroxidation capability of Chinese horseshoe crab hemocyanin50The value was 0.05 mg/mL.
(4) Measurement of hydroxyl radical scavenging ability
Sodium salicylate is free from salicylate in hydrogen peroxide solution, which can react with hydroxyl radical to produce 2, 3-dihydroxybenzoic acid and 2, 5-dihydroxybenzoic acid with color. The colored species has a maximum absorption peak at 510 nm. The absorbance of the reaction can be reduced by adding a substance capable of scavenging hydroxyl radicals to the reaction. The specific steps for determining the scavenging capacity of the hydroxyl free radical are as follows:
taking 0.2mL of hemocyanin solution to a sample tube, and adding 1mL of 2mmol/L FeSO4Solution, 0.4mL of 2mmol/L sodium salicylate solution and 1mL of 0.1% H2O2And (3) solution. The mixture was incubated at 37 ℃ for 1h and, after cooling, the absorbance was measured at 510 nm. According to the formula [ ABlank space-(ASample (I)-AControl)]/ABlank spaceX 100 calculation of clearance, where ABlank spaceI.e. absorbance, A, of the treatment groups without addition of hemocyaninSample (I)I.e. absorbance, A, of the treatment group to which hemocyanin was addedControlI.e. the absorbance of only hemocyanin.
IC for eliminating hydroxyl free radical of Chinese horseshoe crab hemocyanin50The value was 1.63 mg/mL.
The tachypleus tridentatus hemocyanin prepared by the method has good capacity of eliminating free radicals and resisting lipid peroxidation, and can be used in the fields of medicine preparation, food storage, cosmetic preparation and the like.
Claims (10)
1. A method for preparing horseshoe crab hemocyanin is characterized by comprising the following steps:
(1) removing the precipitate after the low-temperature low-speed primary centrifugation of the blood plasma of the tachypleus tridentatus and reserving the supernatant;
(2) and (2) mixing the supernatant obtained by the primary centrifugation in the step (1) with a saturated ammonium sulfate solution according to the ratio of 1: mixing the materials in a volume ratio of 1.5-3, and standing for 10-24 h;
(3) performing low-temperature low-speed secondary centrifugation on the mixed solution after placement in the step (2), collecting precipitates, and suspending the precipitates in a PBS (phosphate buffer solution) with the pH value of 7.0-7.6 to obtain a horseshoe crab hemocyanin crude extract;
(4) and (3) adding the crude limulus hemocyanin extracting solution obtained in the step (3) into a dialysis bag, dialyzing for 12-48 h at 0-4 ℃ by using PBS (phosphate buffer solution) with the pH of 7.0-7.6, and taking a part with the molecular weight of more than or equal to 3500 Da.
2. The method for producing horseshoe crab hemocyanin according to claim 1, wherein the primary centrifugation in step (1) and the secondary centrifugation in step (3) are performed at 0 to 4 ℃ and at 6000 to 8000rpm for 0.5 to 2 hours.
3. The method for producing horseshoe crab hemocyanin according to claim 1, wherein the concentration of the PBS solution in steps (3) and (4) is 0.005 to 0.1 mol/L.
4. The method for producing horseshoe crab hemocyanin having antioxidative activity according to claim 1 or 3, wherein the concentration of PBS solution is 0.01 mol/L.
5. The method for producing horseshoe crab hemocyanin according to claim 1, wherein said horseshoe crab plasma of step (1) is horseshoe crab waste plasma remaining after production of a horseshoe crab reagent.
6. The method for producing horseshoe crab hemocyanin according to claim 1, wherein the dialyzed protein solution of step (4) is freeze-dried or spray-dried.
7. A horseshoe crab hemocyanin produced by the method according to any one of claims 1 to 6.
8. Use of horseshoe crab hemocyanin according to claim 7 for the preparation of an antioxidant.
9. Use of horseshoe crab hemocyanin according to claim 7 for the preparation of cosmetics, foods, food preservatives or pharmaceuticals.
10. A cosmetic or pharmaceutical preparation having an antioxidant activity, which comprises the horseshoe crab hemocyanin of claim 7.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110109125.8A CN112898410B (en) | 2021-01-27 | 2021-01-27 | Tachypleus tridentatus hemocyanin and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110109125.8A CN112898410B (en) | 2021-01-27 | 2021-01-27 | Tachypleus tridentatus hemocyanin and preparation method and application thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112898410A true CN112898410A (en) | 2021-06-04 |
CN112898410B CN112898410B (en) | 2023-06-23 |
Family
ID=76120585
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110109125.8A Active CN112898410B (en) | 2021-01-27 | 2021-01-27 | Tachypleus tridentatus hemocyanin and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112898410B (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113980123A (en) * | 2021-11-26 | 2022-01-28 | 广东海洋大学 | Method for decoppering horseshoe crab hemocyanin and application thereof |
CN118005773A (en) * | 2023-11-24 | 2024-05-10 | 铜陵雅酶生物医药科技有限公司 | Extraction and purification method of arthropod hemocyanin |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106148465A (en) * | 2016-08-09 | 2016-11-23 | 广东海洋大学 | A kind of king crab plasma protein range of hydrolysed peptides with antioxidant activity and its preparation method and application |
WO2018032099A1 (en) * | 2016-08-15 | 2018-02-22 | Rival, Société En Commandite | Preparation process and use of snow crab hemocyanin |
CN108929891A (en) * | 2018-07-27 | 2018-12-04 | 广东海洋大学 | A kind of preparation method of horseshoe crab blood blood cell protein active peptide |
CN108998427A (en) * | 2018-07-27 | 2018-12-14 | 广东海洋大学 | A kind of preparation method of phenoloxidase activity albumen |
-
2021
- 2021-01-27 CN CN202110109125.8A patent/CN112898410B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106148465A (en) * | 2016-08-09 | 2016-11-23 | 广东海洋大学 | A kind of king crab plasma protein range of hydrolysed peptides with antioxidant activity and its preparation method and application |
WO2018032099A1 (en) * | 2016-08-15 | 2018-02-22 | Rival, Société En Commandite | Preparation process and use of snow crab hemocyanin |
CN108929891A (en) * | 2018-07-27 | 2018-12-04 | 广东海洋大学 | A kind of preparation method of horseshoe crab blood blood cell protein active peptide |
CN108998427A (en) * | 2018-07-27 | 2018-12-14 | 广东海洋大学 | A kind of preparation method of phenoloxidase activity albumen |
Non-Patent Citations (7)
Title |
---|
XIMEI LIU ET AL.: ""Enhanced immunity and hemocytes proliferation by three immunostimulants in tri-spine horseshoe crab Tachypleus tridentatus"", 《FISH AND SHELLFISH IMMUNOLOGY》 * |
XIMEI LIU ET AL.: ""Enhanced immunity and hemocytes proliferation by three immunostimulants in tri-spine horseshoe crab Tachypleus tridentatus"", 《FISH AND SHELLFISH IMMUNOLOGY》, vol. 115, 10 June 2021 (2021-06-10), pages 112 - 123 * |
王明华 等: "《高等无机化学简明教程》", vol. 1, 30 September 2016, 冶金工业出版社, pages: 253 - 254 * |
赵忠浩 等: ""中国鲎血蓝蛋白提纯及其纯化物的液相色谱串联质谱分析"", 《水产学报》 * |
赵忠浩 等: ""中国鲎血蓝蛋白提纯及其纯化物的液相色谱串联质谱分析"", 《水产学报》, 26 May 2021 (2021-05-26), pages 1 - 9 * |
金雅芳 等: ""血蓝蛋白提取、纯化、结构表征技术研究进展"", 《食品与药品》 * |
金雅芳 等: ""血蓝蛋白提取、纯化、结构表征技术研究进展"", 《食品与药品》, vol. 15, no. 6, 31 December 2013 (2013-12-31), pages 436 - 439 * |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113980123A (en) * | 2021-11-26 | 2022-01-28 | 广东海洋大学 | Method for decoppering horseshoe crab hemocyanin and application thereof |
CN113980123B (en) * | 2021-11-26 | 2022-06-17 | 广东海洋大学 | Method for decoppering horseshoe crab hemocyanin and application thereof |
CN118005773A (en) * | 2023-11-24 | 2024-05-10 | 铜陵雅酶生物医药科技有限公司 | Extraction and purification method of arthropod hemocyanin |
Also Published As
Publication number | Publication date |
---|---|
CN112898410B (en) | 2023-06-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100999752B (en) | Antioxydizing peptide mixture from collagen and its preparation process and use | |
CN109385457B (en) | Preparation method of giant salamander Maillard peptide with antioxidant activity | |
CN101928742B (en) | Whey protein active peptide with antioxidant activity and preparation method thereof | |
CN107257860B (en) | Chitin, hydrolysate and by means of including the method for being used to produce one or more desired products with the mode of the pretreated enzymatic hydrolysis of oxidant | |
AU666531B2 (en) | Processes for the preparation of amylase inhibitor | |
CN109400678A (en) | A kind of anti-oxidant and DPP-IV inhibitory activity peptide in stichopus japonicus source | |
CN112898410A (en) | Tachypleus tridentatus hemocyanin and preparation method and application thereof | |
KR20170106355A (en) | Chitin, hydrolysates, and methods of producing one or more products of interest from an insect by enzymatic hydrolysis | |
CN113151387B (en) | Cod skin collagen peptide with oxidation resistance and immunity enhancement functions and preparation method thereof | |
CN106666484B (en) | Sturgeon composite powder, sturgeon bone wine and application | |
EP0384796A1 (en) | Method of preparing purified polyphenolic flavan-3-ol type extracts and extracts obtained thereby | |
CN113249421A (en) | Golden-silk-royal chrysanthemum protein polypeptide and preparation and application thereof | |
CN115011660A (en) | Metabolism promoting and oxidation resisting oat protein peptide and preparation method and application thereof | |
Tshinyangu et al. | Protein and chitin nitrogen contents and protein content in Pleurotus ostreatus var. columbinus | |
CN107619411B (en) | Heme extraction method | |
EP1460084B1 (en) | Novel peptide sy | |
CN108048518B (en) | Chicken blood cell antioxidant peptide and enzymolysis preparation method thereof | |
CN108191958B (en) | Linseed meal antioxidant hexapeptide and preparation method and application thereof | |
JPS6287058A (en) | Novel peptide | |
NL9400418A (en) | Processes for the preparation of glutamine-rich peptides and nutritional preparations made therewith. | |
Zhe-fu et al. | Chitinases from seeds of Zea mays and Coix lachryma-jobi L. Purification and some properties | |
CN104970183B (en) | Soluble soybean protein, preparation method and application thereof | |
CN112063481A (en) | Preparation method of giant salamander wine rich in amino acids | |
Sentheshanmuganathan | Some aspects of the destruction of lysine under conditions of acid and enzymic hydrolysis of protein materials containing carbohydrates. | |
CN115181192B (en) | Extraction method of lotus flower stem polysaccharide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Hu Menghong Inventor after: Zhao Zhonghao Inventor after: Jiang Lingfeng Inventor after: Wang Youji Inventor before: Hu Menghong Inventor before: Zhao Zhonghao Inventor before: Wang Youji |
|
GR01 | Patent grant | ||
GR01 | Patent grant |